Y-27632 dihydrochloride, Rho kinase inhibitor (ab120129)
Key features and details
- Selective Rho kinase inhibitor
- CAS Number: 129830-38-2
- Soluble in water to 100 mM and in DMSO to 100mM
- Form / State: Solid
- Source: Synthetic
Overview
-
Product name
Y-27632 dihydrochloride, Rho kinase inhibitor -
Description
Selective Rho kinase inhibitor -
Biological description
Y-27632 is a research tool with a wide variety of biological effects, mainly used in the field of stem cell research for maintenance and differentiation. Commonly used as 3D growth matrix component; also a component of brain organoid differentiation media.
How others have used Y-27632 in their research:
Maintenance of tissue culture of iPSCs; 10 μM Y-27632 for 24 hr; Montefiori et al (2018)
Reprogramming of breast cancer cells to induced progenitor-like cells (iPLs) ; 2 μM Y27632 ; Yuan et al (2018)
Differentiation - Y-27632 enables human embryonic stem cells to survive and differentiate into cortical and basal telencephalic progenitors; Watanabe et al (2007)
*Also available in simple stock solutions (ab144494) - add 1 ml of water to get an exact, ready-to-use concentration.
-
CAS Number
129830-38-2 -
Chemical structure
Properties
-
Chemical name
(R)-(+)-trans-4-(1-Aminoethyl)-N-(4-pyridyl)cyclohexanecarboxamide dihydrochloride -
Molecular weight
320.26 -
Molecular formula
C14H21N3O.2HCl -
PubChem identifier
9901617 -
Storage instructions
Store at +4°C. Store under desiccating conditions. The product can be stored for up to 2 years. -
Solubility overview
Soluble in water to 100 mM and in DMSO to 100mM -
Handling
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Refer to SDS for further information.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
SMILES
Cl.Cl.O=C(Nc1ccncc1)[C@@H]2CC[C@H](CC2)[C@@H](C)N -
Source
Synthetic
-
Research areas
Associated products
-
Related Products
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab120129 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| Functional Studies |
Use at an assay dependent concentration.
|
| Notes |
|---|
|
Functional Studies
Use at an assay dependent concentration. |
Images
-
Chemical Structure - Y-27632 dihydrochloride, Rho kinase inhibitor (ab120129)2D chemical structure image of ab120129, Y-27632 dihydrochloride, Rho kinase inhibitor
-
Functional Studies - Y-27632 dihydrochloride, Rho kinase inhibitor (ab120129)Shiri D et al. PLoS One. 2012; 7(7): e41958. doi: 10.1371/journal.pone.0044400 Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/A: Serum-starved human TM cells were incubated on chamber glass slides coated with recombinant human Gal8 in the presence of the ROCK inhibitor ab120129, at different concentrations. After 2 hr, cells were stained with rhodamine-labeled phalloidin, and cells with robust stress fibers were enumerated. Data are expressed as mean±SEM.
B: Cells were treated with an 120129 (Y27632) at 20 µM, stained with rhodamine-labeled phalloidin, and random fields were photographed. Note that cells treated with ab120129 are not spread and exhibit dendrite-like structures.
Credit: Shiri D et al. PLoS One. 2012; 7(7): e41958. doi: 10.1371/journal.pone.0044400
-
Functional Studies - Y-27632 dihydrochloride, Rho kinase inhibitor (ab120129)ab46154 staining VEGF in HeLa cells treated with Y-27632 dihydrochloride (ab120129), by ICC/IF. Decrease in VEGF expression correlates with increased concentration of Y-27632 dihydrochloride, as described in literature.
The cells were incubated at 37°C for 1h in media containing different concentrations of ab120129 (Y-27632 dihydrochloride) in DMSO, fixed with 100% methanol for 5 minutes at -20°C and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab46154 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
References (94)
ab120129 has been referenced in 94 publications.
- Iouranova A et al. KRAB zinc finger protein ZNF676 controls the transcriptional influence of LTR12-related endogenous retrovirus sequences. Mob DNA 13:4 (2022). PubMed: 35042549
- Elorbany R et al. Single-cell sequencing reveals lineage-specific dynamic genetic regulation of gene expression during human cardiomyocyte differentiation. PLoS Genet 18:e1009666 (2022). PubMed: 35061661
- Napoli M et al. ?Np63 regulates a common landscape of enhancer associated genes in non-small cell lung cancer. Nat Commun 13:614 (2022). PubMed: 35105868
- Rhodes K et al. Human embryoid bodies as a novel system for genomic studies of functionally diverse cell types. Elife 11:N/A (2022). PubMed: 35142607
- Yeh YT et al. Biomechanical interactions of Schistosoma mansoni eggs with vascular endothelial cells facilitate egg extravasation. PLoS Pathog 18:e1010309 (2022). PubMed: 35316298